Skip to main content
drug protocol number
19-504
drug sponsor
King Abdullah Medical City, Holy Capital
drug study
• PANITUMUMAB• OXALIPLATIN• irinotecan• FLOUROURACIL
drug trial site
King Abdullah Medical City (Makkah)
drug status
Ongoing
drug phase